Trypanosoma cruzi: a considerable phylogenetic divergence indicates that the agent of Chagas disease is indigenous to the native fauna of the United States.
Thirty U.S. Trypanosoma cruzi stocks isolated mainly from wild mammals were characterized by multilocus enzyme electrophoresis at 22 genetic loci and random amplification of polymorphic DNA for 10 primers. Two main phylogenetic clusters, separated by large genetic distances, were discriminated by both methods, corresponding, respectively, to the formerly described zymodemes I and III. Two stocks isolated from indigenous human cases were identified as zymodeme I. Genetic diversity of the U.S. T. cruzi isolates was considerable, comparable to that scored in similarly sized samples from South America. These results favor the hypothesis that T. cruzi U.S. stocks were not imported at a historical time and are indigenous to the native fauna of the United States. The population structure of these stocks appeared to be basically clonal, as previously reported in South America, and no evidence of hybrid genotypes was found in the United States.
Barnabé
C
C
Unité de Recherche: "Génétique des Maladies Infectieuses", Montpellier Cedex 01, 34032, France.
Yaeger
R
R
Pung
O
O
Tibayrenc
M
M
D000818:Animals; D001135:Armadillos; D014355:Chagas Disease / Q000453:epidemiology / Q000469:parasitology*; D016000:Cluster Analysis; D004285:Dogs; D004588:Electrophoresis, Cellulose Acetate; D014644:Genetic Variation; D006801:Humans; D015810:Linkage Disequilibrium; D008253:Macaca mulatta; D009893:Opossums; D010802:Phylogeny; D011821:Raccoons; D019105:Random Amplified Polymorphic DNA Technique; D014224:Triatoma; D014349:Trypanosoma cruzi / Q000145:classification* / Q000235:genetics; D014481:United States / Q000453:epidemiology